| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,086 |
25,804 |
$1.72M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,529 |
4,521 |
$365K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,496 |
3,380 |
$198K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,897 |
1,857 |
$184K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,834 |
3,753 |
$139K |
| 99051 |
|
8,172 |
8,028 |
$80K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,549 |
3,433 |
$66K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,777 |
2,725 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,535 |
1,324 |
$30K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
674 |
669 |
$21K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
430 |
426 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,264 |
1,241 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
384 |
379 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
298 |
295 |
$5K |
| 87807 |
|
403 |
394 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
80 |
79 |
$2K |
| 99050 |
|
198 |
190 |
$2K |
| 81002 |
|
1,032 |
1,013 |
$2K |
| 87634 |
|
37 |
37 |
$689.72 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
29 |
29 |
$351.27 |
| 81025 |
|
205 |
202 |
$336.16 |
| 36415 |
Collection of venous blood by venipuncture |
78 |
76 |
$74.35 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
26 |
25 |
$16.04 |
| 99000 |
|
33 |
32 |
$0.00 |